EricLawrenceSimpsonMD

PubMed

• The effect of dupilumab on caregiver- and patient-reported outcomes in young children with moderate-to-severe atopic dermatitis: Results from a placebo-controlled, pha...
  Amy S Paller, Jonathan I Silverberg, Eric L Simpson, Michael J Cork, Peter D Arkwright
  Journal of the American Academy of Dermatology. 2025-01-01
• 1 citations
  A practical guide to using oral Janus kinase inhibitors for atopic dermatitis from the International Eczema Council.
  Carter Haag, Andrew Alexis, Valeria Aoki, Robert Bissonnette, Andrew Blauvelt
  The British Journal of Dermatology. 2024-12-23
• Predicting success with reduced dosing frequency of tralokinumab in patients with moderate-to-severe atopic dermatitis.
  Stephan Weidinger, Anthony Bewley, H Chih-Ho Hong, Juan Francisco Silvestre, Ketty Peris
  The British Journal of Dermatology. 2024-12-05

Journal Articles

• Efficacy and Safety of Baricitinib Combined with Topical Corticosteroids for Treatment of Moderate to Severe Atopic Dermatitis  
  Lawrence F Eichenfield, Eric L Simpson, JAMA Dermatology
• Efficacy and Safety of Abrocitinib in Patients with Moderate-to-Severe Atopic Dermatitis  
  Jonathan I Silverberg, Eric L Simpson, Hernan Valdez, JAMA Dermatology
• Crisaborole Ointment Improves Quality of Life of Patients with Mild to Moderate Atopic Dermatitis and Their Families  
  Jonathan I Silverberg, Amy S Paller, Mark Boguniewicz, Sarah L Chamlin, Eric L Simpson, Lawrence F Eichenfield, Steven R Feldman, Dermatology and Therapy

Lectures

• Atopic Dermatitis 
  American Academy of Dermatology - Annual Meeting 2019 - Washington, D.C. - 3/2/2019